dc.contributor.author | Shiundu, Kevin A | |
dc.date.accessioned | 2022-05-18T07:55:55Z | |
dc.date.available | 2022-05-18T07:55:55Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke/handle/11295/160726 | |
dc.description.abstract | Background: Dolutegravir is highly effective, with a high genetic barrier to HIV grug resistance , and is well tolerated. International studies have assessed the efficacy and non-inferiority of dolutegravir, but more studies are required to assess its clinical effectiveness in resource-constrained settings……………….
………………………………………………………………………………………………………………………………………………………………… | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Nairobi | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.subject | Clinical Effectiveness, Dolutegravir-based Antiretroviral Therapy, Adults Living With HIV, Kenyatta National Hospital | en_US |
dc.title | Assessment of the Clinical Effectiveness of Dolutegravir-based Antiretroviral Therapy Among Adults Living With HIV at the Kenyatta National Hospital | en_US |
dc.type | Thesis | en_US |
dc.description.department | a
Department of Psychiatry, University of Nairobi, ; bDepartment of Mental Health, School of Medicine,
Moi University, Eldoret, Kenya | |